BioRestorative Revenue Per Share from 2010 to 2024

BRTX Stock  USD 1.47  0.02  1.34%   
BioRestorative Therapies Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.03 in 2024. Revenue Per Share is the amount of revenue generated by BioRestorative Therapies per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.03456864
Current Value
0.0328
Quarterly Volatility
300.10589872
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioRestorative Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRestorative Therapies' main balance sheet or income statement drivers, such as Interest Expense of 12.7 K, Selling General Administrative of 7.4 M or Depreciation And Amortization of 177.8 K, as well as many indicators such as Price To Sales Ratio of 47.82, Dividend Yield of 0.0 or PTB Ratio of 0.77. BioRestorative financial statements analysis is a perfect complement when working with BioRestorative Therapies Valuation or Volatility modules.
  
Check out the analysis of BioRestorative Therapies Correlation against competitors.
For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Latest BioRestorative Therapies' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of BioRestorative Therapies over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. BioRestorative Therapies' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioRestorative Therapies' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.05510 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

BioRestorative Revenue Per Share Regression Statistics

Arithmetic Mean143.04
Geometric Mean6.41
Coefficient Of Variation209.80
Mean Deviation194.07
Median30.97
Standard Deviation300.11
Sample Variance90,064
Range981
R-Value(0.32)
Mean Square Error87,278
R-Squared0.10
Significance0.25
Slope(21.24)
Total Sum of Squares1.3M

BioRestorative Revenue Per Share History

2024 0.0328
2023 0.0346
2022 0.0331
2021 0.0387
2020 0.2
2019 23.34
2018 37.86

About BioRestorative Therapies Financial Statements

BioRestorative Therapies investors use historical fundamental indicators, such as BioRestorative Therapies' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRestorative Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.